160 related articles for article (PubMed ID: 7964953)
1. The Pediatric Oncology Group experience with the international staging system criteria for neuroblastoma. Member Institutions of the Pediatric Oncology Group.
Castleberry RP; Shuster JJ; Smith EI
J Clin Oncol; 1994 Nov; 12(11):2378-81. PubMed ID: 7964953
[TBL] [Abstract][Full Text] [Related]
2. Surgical management and outcome of locoregional neuroblastoma: comparison of the Childrens Cancer Group and the international staging systems.
Haase GM; Atkinson JB; Stram DO; Lukens JN; Matthay KK
J Pediatr Surg; 1995 Feb; 30(2):289-94; discussion 295. PubMed ID: 7738753
[TBL] [Abstract][Full Text] [Related]
3. Infants with neuroblastoma and regional lymph node metastases have a favorable outlook after limited postoperative chemotherapy: a Pediatric Oncology Group study.
Castleberry RP; Shuster JJ; Altshuler G; Smith EI; Nitschke R; Winick N; McWilliams N; Joshi V; Hayes FA
J Clin Oncol; 1992 Aug; 10(8):1299-304. PubMed ID: 1634920
[TBL] [Abstract][Full Text] [Related]
4. International neuroblastoma staging system stage 1 neuroblastoma: a prospective study and literature review.
Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Ladanyi M; Gerald WL
J Clin Oncol; 1996 Jul; 14(7):2174-80. PubMed ID: 8683252
[TBL] [Abstract][Full Text] [Related]
5. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma.
Castleberry RP; Kun LE; Shuster JJ; Altshuler G; Smith IE; Nitschke R; Wharam M; McWilliams N; Joshi V; Hayes FA
J Clin Oncol; 1991 May; 9(5):789-95. PubMed ID: 2016621
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of age, MYCN oncogene amplification, tumor cell ploidy, and histology in 110 infants with stage D(S) neuroblastoma: the pediatric oncology group experience--a pediatric oncology group study.
Katzenstein HM; Bowman LC; Brodeur GM; Thorner PS; Joshi VV; Smith EI; Look AT; Rowe ST; Nash MB; Holbrook T; Alvarado C; Rao PV; Castleberry RP; Cohn SL
J Clin Oncol; 1998 Jun; 16(6):2007-17. PubMed ID: 9626197
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic study of localized neuroblastoma European Study Group 94.01 Trial and Protocol.
Navarro S; Amann G; Beiske K; Cullinane CJ; d'Amore ES; Gambini C; Mosseri V; De Bernardi B; Michon J; Peuchmaur M;
J Clin Oncol; 2006 Feb; 24(4):695-9. PubMed ID: 16446343
[TBL] [Abstract][Full Text] [Related]
8. Postoperative treatment of nonmetastatic visible residual neuroblastoma: a Pediatric Oncology Group study.
Nitschke R; Smith EI; Altshuler G; Altmiller D; Shuster J; Green A; Castleberry R; Hayes FA; Golembe B; Ducos R
J Clin Oncol; 1991 Jul; 9(7):1181-8. PubMed ID: 2045858
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of MYCN amplification and ploidy in favorable-stage neuroblastoma: a report from the Children's Oncology Group.
Schneiderman J; London WB; Brodeur GM; Castleberry RP; Look AT; Cohn SL
J Clin Oncol; 2008 Feb; 26(6):913-8. PubMed ID: 18281664
[TBL] [Abstract][Full Text] [Related]
10. A comparison of four staging systems for localized and regional neuroblastoma: a report from the Childrens Cancer Study Group.
Evans AE; D'Angio GJ; Sather HN; de Lorimier AA; Dalton A; Ungerleider RS; Finklestein JZ; Hammond GD
J Clin Oncol; 1990 Apr; 8(4):678-88. PubMed ID: 2313336
[TBL] [Abstract][Full Text] [Related]
11. Significance of clinical and biologic features in Stage 3 neuroblastoma: a report from the International Neuroblastoma Risk Group project.
Meany HJ; London WB; Ambros PF; Matthay KK; Monclair T; Simon T; Garaventa A; Berthold F; Nakagawara A; Cohn SL; Pearson AD; Park JR
Pediatr Blood Cancer; 2014 Nov; 61(11):1932-9. PubMed ID: 25044743
[TBL] [Abstract][Full Text] [Related]
12. Lymph node sampling in localized neuroblastoma: a Pediatric Oncology Group study.
Contador MP; Johnston S; Smith EI; Shuster JJ; Hayes FA; Castleberry RP
J Pediatr Surg; 1999 Jun; 34(6):967-74. PubMed ID: 10392915
[TBL] [Abstract][Full Text] [Related]
13. The role of bone marrow evaluation in the staging of patients with otherwise localized, low-risk neuroblastoma.
Russell HV; Golding LA; Suell MN; Nuchtern JG; Strother DR
Pediatr Blood Cancer; 2005 Dec; 45(7):916-9. PubMed ID: 16078212
[TBL] [Abstract][Full Text] [Related]
14. Survival from locally invasive or widespread neuroblastoma without cytotoxic therapy.
Kushner BH; Cheung NK; LaQuaglia MP; Ambros PF; Ambros IM; Bonilla MA; Gerald WL; Ladanyi M; Gilbert F; Rosenfield NS; Yeh SD
J Clin Oncol; 1996 Feb; 14(2):373-81. PubMed ID: 8636746
[TBL] [Abstract][Full Text] [Related]
15. Successful treatment of stage III neuroblastoma based on prospective biologic staging: a Children's Cancer Group study.
Matthay KK; Perez C; Seeger RC; Brodeur GM; Shimada H; Atkinson JB; Black CT; Gerbing R; Haase GM; Stram DO; Swift P; Lukens JN
J Clin Oncol; 1998 Apr; 16(4):1256-64. PubMed ID: 9552023
[TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of the International Neuroblastoma Staging System (INSS) and the International Neuroblastoma Response Criteria (INRC) in a multicentre setting.
Castel V; García-Miguel P; Cañete A; Melero C; Navajas A; Ruíz-Jiménez JI; Navarro S; Badal MD
Eur J Cancer; 1999 Apr; 35(4):606-11. PubMed ID: 10492635
[TBL] [Abstract][Full Text] [Related]
17. A surgical perspective on the current staging in neuroblastoma--the International Neuroblastoma Staging System proposal.
Smith EI; Haase GM; Seeger RC; Brodeur GM
J Pediatr Surg; 1989 Apr; 24(4):386-90. PubMed ID: 2732883
[TBL] [Abstract][Full Text] [Related]
18. N-Myc gene amplification is a major prognostic factor in localized neuroblastoma: results of the French NBL 90 study. Neuroblastoma Study Group of the Société Francaise d'Oncologie Pédiatrique.
Rubie H; Hartmann O; Michon J; Frappaz D; Coze C; Chastagner P; Baranzelli MC; Plantaz D; Avet-Loiseau H; Bénard J; Delattre O; Favrot M; Peyroulet MC; Thyss A; Perel Y; Bergeron C; Courbon-Collet B; Vannier JP; Lemerle J; Sommelet D
J Clin Oncol; 1997 Mar; 15(3):1171-82. PubMed ID: 9060561
[TBL] [Abstract][Full Text] [Related]
19. Review of image defined risk factors in localized neuroblastoma patients: Results of the GPOH NB97 trial.
Simon T; Hero B; Benz-Bohm G; von Schweinitz D; Berthold F
Pediatr Blood Cancer; 2008 May; 50(5):965-9. PubMed ID: 17914735
[TBL] [Abstract][Full Text] [Related]
20. Proliferation marker KI-S5 discriminates between favorable and adverse prognosis in advanced stages of neuroblastoma with and without MYCN amplification.
Krams M; Hero B; Berthold F; Parwaresch R; Harms D; Rudolph P
Cancer; 2002 Feb; 94(3):854-61. PubMed ID: 11857322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
